Thieler Law Corp advises investors with losses exceeding $100,000 of the March 14, 2016 lead plaintiff deadline in a class action lawsuit filed against Esperion Therapeutics Inc (NASDAQ: ESPR) (“Esperion” or “the Company”). The suit is pending in the U.S. District Court for the Eastern District of Michigan and investors, who purchased Esperion Therapeutics Inc securities between August 18, 2015 and September 28, 2015, have until March 14, 2016 to move for lead plaintiff. You do not need to move for lead plaintiff to be a member of the Class.

If you purchased Esperion Therapeutics Inc securities during the Class Period, and have losses over $100,000, you may contact Thieler Law Corp by calling at (619) 377 - 4324 or emailing mail@thielerlaw.com .  No class has been certified in this case, and if your losses are less than $100,000 you are still a member of the class.

The complaint alleges that during the Class Period defendants made false and misleading statements and/or allegedly failed to disclose that that there was no clear path to approval for ETC-1002, and that the FDA had encouraged the Company to initiate a cardiovascular outcomes trial ("CVOT") and the completion of a CVOT could be necessary prior to approval of ETC-1002.

On August 17, 2015, Esperion disclosed to investor's material events from a meeting with the FDA on August 2015, Esperion revealed that during the meeting it was informed by the FDA that Esperion would not have to complete a CVOT to gain approval of ETC-1002.

On September 28, 2015, it was revealed that Esperion Therapeutics Inc noted that the FDA had encouraged Esperion to initiate a cardiovascular outcomes trial promptly and it may be necessary to have a completed CVOT prior to approval.

Following this news, NASDAQ: ESPR declined to as low as $18.07 per share on September 29, 2015.

If you were negatively impacted by your investment in Esperion Therapeutics Inc securities between August 18, 2015 and September 28, 2015 and would like to learn more about this lawsuit and your ability to participate as a lead plaintiff, please contact us for your no-cost evaluation.

Thieler Law Corp purchases advertisements on search engines, social media sites and other websites. If you send us information, note that does not create an attorney-client relationship with the firm.

Thieler Law Corp

2534 State Street - Suite 406,

San Diego, CA 92101

by

email: mail@thielerlaw.com

or

telephone at +1 (619) 377 - 4324

or

visit our website http://www.thielerlaw.com/

or

Facsimile: +1 (619) 785 – 3185